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As the importanceofpelvic venousdisorders (PeVD)hasbeen increasingly recognized, progress in thefieldhasbeen limitedby
the lack of a valid and reliable classification instrument. Misleading historical nomenclature, such as the May-Thurner, pelvic
congestion, and nutcracker syndromes, often fails to recognize the interrelationship of many pelvic symptoms and their un-
derlying pathophysiology. Based on a perceived need, the American Vein and Lymphatic Society convened an international,
multidisciplinary panel chargedwith the development of a discriminative classification instrument for PeVD. This instrument,
theSymptoms-Varices-Pathophysiology (“SVP”) classification forPeVD, includes threedomainsdSymptoms (S),Varices (V),and
Pathophysiology (P), with the pathophysiology domain encompassing the Anatomic (A), Hemodynamic (H), and Etiologic (E)
features of the patient’s disease. An individual patient’s classification is designated as SVPA,H,E. For patients with pelvic origin
lower extremity signs or symptoms, the SVP instrument is complementary to and should be used in conjunction with the
Clinical-Etiologic-Anatomic-Physiologic (CEAP) classification. The SVP instrument accurately defines the diverse patient
populations with PeVD, an important step in improving clinical decision making, developing disease-specific outcomemea-
sures and identifying homogenous patient populations for clinical trials. (J Vasc Surg Venous Lymphat Disord 2021;9:568-84.)
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d Type of Research: Multispecialty, intersocietal devel-
opment of a discriminative classification instrument
d Key Findings: The clinical presentation of patients
with pelvic venous disorders can be accurately and
fully characterized by a discriminative instrument
that includes presenting symptoms (S), the involved
variceal reservoirs (V), and the underlying pathophys-
iology (P), which includes the anatomic (A), hemody-
namic (H), and etiologic (E) features of the disease. A
patient’s presentation is summarized as SVPA,H,E.
d Take Home Message: The use of historical nomencla-
ture for pelvic venous disorders fails to recognize the
complex and interrelated pelvic venous circulation,
contributes to misdiagnosis and poor treatment out-
comes, and hinders clinical research. In defining
homogenous patient populations, the Symptoms-
Varices-Pathophysiology instrument will facilitate clin-
ical communication, allow treatment to be more
precisely directed, and facilitate the development of
patient-reported outcomemeasures and clinical trials.
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Volume 9, Number 3confused the underlying pathophysiology and led to
diagnostic errors and suboptimal treatment outcomes.
Furthermore, the lack of a robust classification system
defining homogenous patient populations limits clinical
communications, makes interpretation of the literature
difficult, and hinders the development of appropriate
clinical trials. The existence of pelvic venous disorders
(PeVD) and their appropriate treatment has also been
questioned owing to the lack of validated definitions
and imaging criteria as well as rigorous randomized clin-
ical trials.1 There is a critical need for a classification sys-
tem for PeVD that recognizes the variable, but often
overlapping, clinical presentations, as well as the underly-
ing pathophysiology. A multidisciplinary panel has
ranked the development of validated diagnostic criteria
and a discriminative classification instrument as the
most important research priorities for PeVDs.1
For venous disorders of the lower extremities, the
Clinical-Etiologic-Anatomic-Physiologic (CEAP) classifi-
cation, originally published in 19962 and revised in
20043 and 2020,4 has become the international standard
for classification of these disorders. By defining patient
groups with similar clinical presentations and patho-
physiologic features, the instrument has facilitated clin-
ical communication regarding individual patients and
is recognized as a reporting standard for clinical research.
Despite its usefulness and general acceptance, the CEAP
classification system is limited to lower extremity venous
disorders. Since its original description, rapid advance-
ments in diagnostic imaging and catheter-based inter-
ventions have improved our understanding of disorders
arising from veins other than those in the legs, particu-
larly those of pelvic and abdominal origin.
Venous disorders of the pelvis are associated with a
spectrum of symptoms arising from both reflux, most
commonly involving the gonadal and internal iliac veins,
and obstruction, usually of the left renal and iliac veins.
These hemodynamic patterns are associated with at
least four broad clinical presentations, including (a) left
flank or abdominal pain and hematuria (left renal vein
compression), (b) chronic pelvic pain (pelvic varicosities
associated with primary reflux in the ovarian/internal iliac
veins or obstruction of the left renal or common iliac
veins), (c) venous claudication (iliac venous obstruction),
and (d) symptomatic lower extremity varicosities in
either atypical (vulva/testicles, medial and posterior
thigh, sciatic nerve) or typical saphenous distributions,
the latter frequently recurring after initial treatment.
The relationship between pelvic symptoms and venous
pathology is far more complex than in the lower extremity.
Multiple symptoms may be present concurrently and
several potential pathophysiologic mechanisms, such as
left renal and iliac venous compression, may be simulta-
neously present. Additionally, similar symptoms may arise
from disparate underlying causes (eg, chronic pelvic pain
can arise from primary ovarian vein reflux, left commoniliac vein compression, or left renal vein compression),
and similar anatomic derangements may lead to different
symptoms (eg, left renal vein compression may be associ-
ated with either left flank pain and hematuria or chronic
pelvic pain). This can lead to diagnostic errors and may
be responsible for the suboptimal results of many inter-
ventions.5,6 From a research perspective, appropriate pa-
tient classification is also important in ensuring
homogenous patient populations for the development
of disease-specific outcome instruments and clinical trials.
There is thus a critical need for precise classification of
PeVDs that has implications for both individual patient
management and future clinical research.
METHODS
Based on the need for a classification instrument for
PeVD, the American Vein and Lymphatic Society
convened an International Working Group on Pelvic
Venous Disorders in Chicago, Illinois, on July 27, 2018. In-
ternational societies representing the broad spectrum of
specialties involved in the care of patients with PeVD,
including gynecologists, interventional radiologists,
vascular surgeons, and phlebologists, were invited to
participate either in-person or remotely. Invited societies
and their representatives are listed in Table I.
The specific goal of the group was to develop a discrim-
inative classification instrument for PeVDs. Discriminative
instruments are designed to measure cross-sectional dif-
ferences between individuals at a single point in time, as
opposed to evaluative instruments that measure longitu-
dinal changes within people over time.7,8 Discriminative
instruments include key components of the disease
Table I. International Working Group on Pelvic Venous
Disorders (PeVDs) Participants
Contributor Affiliation
Diana Atashroo, MD International Pelvic Pain Society
(IPPS)
Antonio Basile, MD Cardiovascular and
Interventional Radiological
Society of Europe (CIRSE)
Antonio Gasparis, MD American Venous Forum (AVF)
Kathleen Gibson, MD American Vein and Lymphatic
Society (AVLS)
Milka Greiner, MD, PhD European Venous Forum (EVF)
Nicos Labropoulos, PhD International Union of
Phlebology (UIP)
Zaza Lazarashvilli, MD International Union of
Phlebology (UIP)
Lee Learman, MD, PhD American College of
Obstetricians and
Gynecologists (ACOG)
Joanne Lohr, MD American Venous Forum (AVF)
Neil Khilnani, MD Society of Interventional
Radiology (SIR)
Man-Deuk Kim, MD, PhD Korean Society of Interventional
Radiology
Fedor Lurie, MD, PhD Society for Vascular Surgery
Mark Meissner, MD American Vein and Lymphatic
Society (AVLS)





Marc Passman, MD Society for Vascular Surgery
Mel Rosenblatt, MD American Vein and Lymphatic
Society (AVLS)
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limited number of options and clear definitions that
enable uniform interpretation, and have large and stable
between-subject variation.8 From a simplistic standpoint,
discriminative instruments place patients into homoge-
nous groups with similar clinical features, natural his-
tories, and responses to treatment.
At the initial meeting, the clinical, anatomic, and path-
ophysiologic aspects of PeVD were presented and dis-
cussed among panel members, incorporating the views
of the various subspecialties included on the panel. The
methodology underlying instrument development was
then reviewed and alternative approaches discussed.
Based on this discussion, it was agreed that the instru-
ment should be based on the following principles.
a. The instrument should be patient-centric, that is,
focused on the primary concerns of the patient rather
than simply the underlying pathophysiology.
b. In addition to patient-important clinical features,
complete characterization of a patient’s presentation
requires a precise description of the underlying anat-
omy and pathophysiology.c. Asymptomatic patients with pelvic venous disease
should be included in the classification, although
among symptomatic patients, only those with a
recognized venous etiology should be included.
Similar clinical presentations that are not of venous
origin (eg, chronic pelvic pain owing to other causes)
are not included in this classification.
d. Several nuances of PeVD, particularly the observation
that PeVD are primarily symptom rather than sign
based, preclude a purely CEAP-based approach. How-
ever, because venous disorders of the pelvis and lower
extremity are a continuum, the instrument should, as
much as feasible, follow the conventions of and be
complementary to CEAP. Accordingly, the pelvic in-
strument should avoid duplication of lower extremity
signs that are included in CEAP. For example,
although localized pelvic origin extrapelvic symptoms,
such as tenderness associated with pelvic origin vari-
cosities, should be included in the pelvic instrument,
more generalized lower extremity signs, such as
swelling continue to be best classified with CEAP.
Guided by these principles, the domains to be included
were discussed and precise definitions developed,
emphasizing the importance of optimizing the validity
and reproducibility of the instrument. Small groups
were then formed to craft an initial strategy for each
domain, which was then discussed among the entire
group. Based on the discussion, a draft instrument (the
SVP classification) was developed and three rounds of
simulated patient classification performed by the writing
group (M.H.M., N.K., N.L., A.G., K.G., and M.G.) to identify
potential problems with the definitions and ensure
reproducibility of the instrument. Definitions were
further refined based on the simulated classification ex-
ercises and review of the literature, striving to make
them as evidence based as possible. The final draft was
then circulated to all participants for revision.RESULTS: THE CLASSIFICATION OF PeVD
Definitions
Minimizing interobserver variability through precise
definitions is critical to the reproducibility of a discrimi-
native instrument. The following definitions were devel-
oped and should be utilized for the purpose of pelvic
venous classification. When possible, efforts were made
to make these definitions congruent with lower extrem-
ity CEAP.
Symptoms.
PeVDdThe spectrum of symptoms and
signs arising from the veins of the pelvis
(the gonadal veins, the internal iliac veins
and their tributaries, and the venous plex-
uses of the pelvis) and their primary
drainage pathways (the left renal vein, the
iliac veins, and the pelvic escape points).
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Volume 9, Number 3This includes symptoms historically ascribed to
the May-Thurner, nutcracker, and pelvic conges-
tion syndromes. Given their imprecise and overlap-
ping nature, these historical terms should no
longer be used.1
Venous origin renal symptomsdSymptoms arising from
renal venous hypertension secondary to left renal vein
obstruction.
These include microhematuria or macrohematu-
ria and left flank or abdominal pain that is wors-
ened by activities such as standing, sitting, or
walking.9
Chronic pelvic paindPain symptoms perceived to origi-
nate from pelvic organs/structures typically lasting
more than 6 months. It is often associated with negative
cognitive, behavioral, sexual, and emotional conse-
quences as well as with symptoms suggestive of lower
urinary tract, sexual, bowel, pelvic floor, myofascial, or gy-
necologic dysfunction.10
Although there has historically been a lack of
consensus11 regarding the definition of chronic
pelvic pain, we have adopted that proposed by
the American College of Obstetricians and Gyne-
cologists. Causes of chronic pelvic pain include a
wide range of disorders of the reproductive, uri-
nary, gastrointestinal, neurologic, and musculo-
skeletal systems,12 often with overlapping
symptoms in an individual patient.13 PeVD are
included in the range of somatic, visceral and
neurologic pain generators that are often associ-
ated with chronic pelvic pain.
Data regarding the demographics and symptom-
atology of women with venous origin pelvic pain
are largely derived from small case series of those
presenting for treatment and there is a clear need
for larger studies comparing women with chronic
pelvic pain of venous and nonvenous origin. Such
limited case series suggest that venous origin pel-
vic pain most commonly occurs in multiparous
women of reproductive age.12,14-16 Despite this
general observation, a somewhat older population
with iliac venous obstruction has recently been
described in which pelvic pain often occurs in
conjunction with leg symptoms,17,18 implying that
patient demographics and associated symptoms
may depend on the underlying etiology.
Because chronic pelvic pain includes a spectrum
of symptoms, there is substantial overlap between
women with pain secondary to venous and nonve-
nous causes. Descriptions of the typical character-
istics of venous origin pelvic pain come largely
from a single dated but well-done study
comparing women with pelvic pain and varices
on transuterine venography to women with either
pelvic pain owing to other pathology or without
pelvic pain undergoing elective sterilization.15
Most of the signs and symptoms associated with
venous-origin pelvic pain have been found to be
relatively sensitive, but nonspecific.19 Pelvic pain
of venous origin is often characterized as dullunilateral or bilateral pain with occasional sharp
flares. Bimanual examination, demonstrating focal
adnexal tenderness, often reproduces the pain.
Symptoms are often worse with activities such as
walking and prolonged standing, and improve
with lying down. Although deep dyspareunia is
common among women with pelvic pain from a
variety of causes, venous origin pain is more likely
to be associated with prolonged postcoital
ache.12,15,19 The combination of postcoital ache
and tenderness over the ovarian point (the junc-
tion of the upper andmiddle thirds of a line drawn
from the umbilicus to the anterior superior iliac
spine) has been reported to be 94% sensitive and
77% specific for distinguishing a venous origin
from other causes of pelvic pain.15
Although chronic pelvic pain also occurs in
males,20,21 there is currently little evidence to sug-
gest that pelvic venous disease is an important
contributing factor. This is likely due to both differ-
ences in venous anatomy as well as the role of
pregnancy in PeVDs in women. The gonadal veins
follow an extrapelvic course in males and the
arrangement of the visceral pelvic venous plexuses
are substantially different.
Pelvic origin extrapelvic symptomsdSymptoms local-
ized to the external genitalia or lower extremities that
arise from either reflux through recognized escape
points in the pelvic floor22 or from iliocaval venous
obstruction.
In females, reflux-related symptoms may include
pain, discomfort, tenderness, itching, bleeding,
and superficial venous thrombosis associated
with nonsaphenous varicosities. These may be
localized to the vulva or the posteromedial thigh
in the distribution of the perineal and inferior
gluteal escape points. In males, these include
testicular discomfort and infertility related to a
varicocele. Extrapelvic reflux arising from the infe-
rior gluteal vein may also rarely be associated with
sciatic or tibial nerve symptoms. Symptoms associ-
ated with sciatic nerve varices include pain radi-
ating from the buttock to the lateral aspect of
the leg, often worsened with sitting.23,24 Anecdotal
reports suggest tibial nerve symptoms are milder,
often including only paresthesias on compression
of the nerve. Obstruction-related extrapelvic
symptoms include venous claudication.
Venous claudicationdExertional pain in the lower ex-
tremities frequently described as a tight, "bursting"
pain, in the thigh, buttock, or leg not associated with a
specific walking distance or confined to specific muscle
groups, but relieved by rest and elevation of the legs.25-28
Symptoms of venous claudication are most commonly
associated with iliocaval venous obstruction.
HASTI (Provensis, Uxbridge, UK) symptomsdNonspecific
symptoms typically associated with lower extremity
venous disease including heaviness (H), aching (A),
swelling (S), throbbing (T), and itching (I).27,29
Such symptoms are usually generalized to the
lower extremity rather than localized to any pelvic
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Although the responsible pathology may arise in
the pelvis, generalized signs of lower extremity
venous disease are not included in the SVP classi-
fication and should be accounted for by the con-
current use of CEAP.
Signs.
Left renal vein obstructiondCompression of the
left renal vein at the crossing of the abdominal
aorta associated with symptoms related either
to (a) renal venous hypertension (hematuria
and/or abdominal/flank pain) or (b) if decom-
pressed by collaterals, pelvic varices and chronic
pelvic pain or a left-sided varicocele.
Symptomatic obstruction of the left renal vein is
usually attributed to compression of the renal
vein between the abdominal aorta and superior
mesenteric artery (anterior nutcracker syndrome),
although compression may also arise from a retro-
aortic course of the left renal vein (posterior
nutcracker syndrome) or stretching of the renal
vein over the abdominal aorta.9 Symptoms of
flank pain and hematuria are presumed second-
ary to renal venous hypertension, often defined
as a transrenal pressure gradient of 3 or more
mm Hg at the time of venography.30-33 Hematuria
in such cases is often attributed to renal varices,
which are often asymptomatic, effect predomi-
nantly the left kidney, and have been identified
in 10% of left renal venograms performed for a va-
riety of indications.34 However, such a gradient
may be absent it there is significant decompres-
sion via refluxing collaterals including the left
gonadal, ascending lumbar, adrenal, periureteral,
capsular, or intrarenal veins.9,31 In such cases, pelvic
varices or a varicocele may be associated with sec-
ondary gonadal vein reflux.
A variety of imaging modalities including ultra-
sound, venography (with or without intravascular
ultrasound [IVUS] and measurement of pressure
gradients), computed tomography (CT), and mag-
netic resonance imaging (MRI) have been used in
the evaluation of left renal vein compression.
Although mean renal vein diameter reduction by
CT is significantly higher in patients with symp-
toms related to renal venous hypertension
(74.5 6 1.9%) than in controls (25.4 6 2.4%)35 and
a transrenal pressure gradient of 3 or more mm
Hg has been associated with hematuria,30-32 defin-
itive diagnostic criteria and cut-points are lacking
and may vary between patients. Furthermore,
asymptomatic 50% or greater compression of
the left renal vein (nutcracker phenomenon) is
seen in 51% to 72% of CT angiograms.32 Given
the lack of definitive anatomic and hemodynamic
criteria across a variety of clinical settings, we have
not included them in the definition, which instead
relies on correlating the patient’s symptoms and
imaging studies.Pelvic varicose veinsdTortuous, dilated veins 5 mm or
more in diameter around the ovary and uterus.36
Pelvic varices may involve both the ovarian (pam-
piniform) and uterovaginal venous plexuses, which
communicate through the broad ligament.12,22,37-39
There may also be extensive communication with
the vesicular and external rectal plexus.22 Although
venography has historically been the reference
standard for the diagnosis of pelvic varices,14,37,39 it
remains an invasive study associated with the risks
of ionizing radiation and is now often limited to
definitive imaging at the time of planned interven-
tion. Several noninvasive imaging studies,37,40 more
suitable for initial evaluation, have been suggested
including transabdominal ultrasonography, trans-
vaginal ultrasonography, CT, and MR imaging.
Among these, pelvic ultrasound, either transabdo-
minal or transvaginal, is the most widely available,
has been the most extensively investigated, and al-
lows an evaluation of both venous diameter and
reflux. We have accordingly defined pelvic varices
based on commonly cited ultrasound criteria.36
Other diagnostic criteria have been proposed,
including greater than 4 tortuous, dilated veins
greater than 4 mm in diameter surrounding the
ovaries and uterus,41 the appearance of dilated
transuterine veins (arcuate and/or myometrial
veins) connecting the left and right uterine veins,37
and reversed flow direction or disappearance of
flow with Valsalva.37,40,42 However, Park et al36
found transuterine crossing veins in only 25% of pa-
tients with symptomatic pelvic varicosities in com-
parison with 8.6% of controls. Similarly, reversal of
Doppler flow direction during a Valsalva maneuver
was identified in only 26.9% of symptomatic pa-
tients, in comparison with 8.8% of controls.36
Position does influence the ability to detect pelvic
venous pathology. Investigators have reported ul-
trasound evaluation in the supine,36 30 to 45
reverse Trendelenburg position,42,43 semi-erect,44
and upright positions.43 CT and MR imaging are
obligatorily performed in the supine position.
Because there is no consensus regarding posi-
tioning for noninvasive examinations, it has not
been included in the definitions of pelvic varicose
veins or reflux. However, clinicians should be
aware of the role that position may have in the
interpretation of all imaging studies.
Gonadal vein refluxdRetrograde flow in either gonadal
vein, spontaneously or in response to a Valsalva’s maneu-
ver, as documented by ultrasound, venography, or time
resolved magnetic resonance angiography.
Retrograde flow is the primary criteria for the defi-
nition of venous reflux and in the left ovarian vein,
has been identified in 100% of patients with symp-
tomatic pelvic varices in comparison with 25% of
controls.41 Although some investigators45 have
defined pelvic reflux as retrograde flow greater
than 1 second in duration and persisting until the
end of the maneuver, other investigators41,46 have
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Volume 9, Number 3noted no validated cut-point for pathologic dura-
tion of reflux in the ovarian veins. Still other inves-
tigators have noted variable reflux patterns,
including spontaneous, intermittent retrograde
flow; retrograde flow only during a Valsalva ma-
neuver; and continuous retrograde flow.47 Given
the conflicting evidence, we have chosen not to
include reflux duration in the definition.
Gonadal vein diameter, in the presence of pelvic
varices is often used as a surrogate for retrograde
flow. Although some investigators44,45,48 have re-
ported ovarian vein diameter to be an insensitive
maker of reflux, other investigators36 have re-
ported positive predictive values of 71.2%, 83.3%,
81.8%, and 75.8% for diameters of 5, 6, 7, and
8 mm, respectively. Other investigators41 have
similarly found pelvic varices to be present in all
patients with a left ovarian vein diameter of
more than 6 mm by ultrasound assessment.
Diameter criteria have also been reported for CT
and MR.40 However, in view of the conflicting evi-
dence, we have not included diameter as a criteria
for gonadal vein reflux.
Iliac venous obstructiondGreater than 50% cross-
sectional area reduction by IVUS or a 50% or greater
diameter reduction by multiplanar venography of the
common or external iliac veins in association with appro-
priate lower extremity or pelvic symptoms.
This definition was derived from those commonly
used in the literature, although it must be
acknowledged that there is currently no validated
method of defining a clinically or hemodynamical-
ly significant venous stenosis49-51 and that this
value may differ between patients.52 In evaluating
the predictors of clinical improvement after iliac
venous stenting, a cross sectional area reduction
of more than 54% by IVUS examination had the
highest sensitivity (83% sensitivity, 47% specificity),
whereas a greater than 52% diameter decrease by
multiplanar venography had the highest speci-
ficity (50% sensitivity, 71% specificity).49 Notably,
the thresholds for clinical improvement after
stenting were somewhat higher for nonthrom-
botic lesions. However, because a 50% or greater
iliac stenosis may be present in one-quarter to
one-third of the general population,52,53 it is critical
that anatomic stenosis alone not be considered a
criterion for intervention and that any
measurement of stenosis be interpreted in the
context of the patient’s clinical presentation.
Both cross-sectional imaging and transabdominal
ultrasound examination have been used in the
initial evaluation of iliac obstruction and a number
of ultrasound criteria for detection of a 50% or
greater iliac venous obstruction have been
developed.51,53
Internal iliac venous refluxdRetrograde flow in the inter-
nal iliac vein or its tributaries, either spontaneously or in
response to a provocative Valsalva’s maneuver.
Reflux can be demonstrated by antegrade or se-
lective descending venography, transabdominal/transperineal ultrasound,43,47 or transvaginal ultra-
sound.42,44 Pathologic flow patterns observed with
ultrasound include retrograde flow isolated to the
main internal iliac trunk, cephalad flow in the
main trunk and reflux in the tributaries, or retro-
grade flow in both the main trunk and tributaries.
Pelvic origin extrapelvic varicesdRetrograde flow in
extrapelvic veins arising from reflux exiting the pelvis
through recognized escape points.22
Pelvic origin extrapelvic varices include refluxing
veins in either atypical locations (vulva in females
and pampiniform plexus in males, perineum,
gluteal cleft, and posterior thighs), or, through
communication with saphenous tributaries, in a
typical saphenous distribution. Extrapelvic varices
also include intra/perineural (sciatic and tibial)
varices arising from the inferior gluteal tributary
of the internal iliac vein.22,54
As elsewhere, this is an ultrasound-derived defini-
tion that includes both visible varicosities as well
as refluxing pelvic-origin tributaries that are seen
only with ultrasound. Protocols for visualization of
these refluxing tributaries are well-defined
elsewhere.43
Pelvic origin extrapelvic varices may arise from
either pelvic reflux or obstruction. However, by
definition, collateral veins from the lower extrem-
ity to the pelvis that demonstrate antegrade flow
at rest and function to bypass an iliocaval venous
obstruction are not pelvic origin extrapelvic
varices.
Lower extremity varicesdAs defined in CEAP,3 subcu-
taneous, dilated veins $3 mm in diameter which
demonstrate reflux in the upright position and involve
the named saphenous and accessory saphenous trunks,
their tributaries and nonsaphenous superficial leg veins.CLASSIFICATION OF PeVDsDTHE SVP
INSTRUMENT
Discriminative instruments for venous disorders consist
of descriptive domains or categories, such as the clinical
(C), etiologic (E), anatomic (A), and pathophysiologic (P)
domains of CEAP, with precisely defined responses within
each domain. The proposed classification for PeVDs has
beendesignated the SVPclassification and includes three
domains: symptoms (S), varices (V), the primary sign of
PeVD, and a composite anatomic-pathophysiologic
domain (P). ThecompositePdomain is composedof three
subdomains, including the anatomy of the involved
abdominal and pelvic veins (A), the associated hemody-
namic abnormalities (H), and the underlying etiology (E),
which are listed as subscripts after the P domain (PA,H,E).
An individual patient’s pelvic classification is thus desig-
nated as SVPA,H,E.
Symptoms (S) and varices (V) associated with PeVD are
considered to occur in 4 anatomic zones extending in a
descending fashion from the renal veins to the lower ex-
tremities (Fig 1). Three of these zonesd(1) the left renal
Fig 1. The symptoms, signs (varices), and pathophysiologic manifestations of pelvis venous disorders (PeVD) occur
in four anatomic zones of the abdomen and pelvis. These are arranged in descending order from the renal veins
to the lower extremities and include symptoms and varices associated with (1) the left renal vein, (2) the gonadal,
internal iliac, and pelvic veins, (3) the pelvic origin extrapelvic veins arising in the pelvis and refluxing through the
pelvic escape points to the genitalia and lower extremity veins, and (4) the lower extremity veins. The first three
zones are included in the Symptoms-Varices-Pathophysiology (SVP) classification while the fourth zone, associ-
ated with the superficial and deep veins of the lower extremity and their tributaries, is optimally classified with
CEAP and is not included. L, left; R, right.
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ated pelvic venous plexuses, and (3) the pelvic origin
extrapelvic transitional veins arising from reflux exiting
the pelvis through recognized escape pointsdare
included in the SVP classification. Although often
communicating with zone 3, the fourth zone, the super-
ficial and deep veins of the lower extremity and their trib-
utaries, is optimally classified with CEAP and is not
included in the SVP instrument.
Each of the three primary domainsdsymptoms (S), vari-
ces (V), and pathophysiology (P) with its 3 subdomainsd
is discussed in this section.
Symptoms (S). Pelvic venous classification begins with
the patient’s clinical symptoms (S) designated bysubscripts from 0 through 3 (Table II). As discussed
elsewhere in this article, responses are arranged in
descending anatomic zones from the renal veins to the
lower extremities. Although some complaints may occur
in either sex, others such as pelvic pain and varicocele
occur predominantly or exclusively in one sex. Venous
origin extrapelvic symptoms (S3) are further subdivided
into those involving the external genitalia, those related
to pelvic origin nonsaphenous varicosities of the leg
(posteromedial thigh and sciatic/tibial nerve), and those
of venous claudication.
The pelvic origin extrapelvic veins of the thigh may
communicate with the superficial and deep veins of
the lower extremity and be associated with any of the
manifestations of C2 through C6 disease. Although
Table II. Symptoms (“S”)
S0
No symptoms of a PeVD (no renal, pelvic, or extrap-
elvic symptoms)
S1 Renal symptoms of venous origin
S2 Chronic pelvic pain of venous origin
S3 Extrapelvic symptoms of venous origin
a Localized symptoms (pain, discomfort, tenderness,
itching, bleeding and superficial venous
thrombosis) associated with veins of the external
genitalia (vulva and scrotum)
b Localized symptoms associated with pelvic origin
nonsaphenous veins of the leg. These include those
related to pelvic origin varices of the posteromedial
thigh (pain, discomfort, tenderness, itching,
superficial venous thrombosis) as well as those
related to sciatic/tibial nerve varices (pain,
paresthesias). More generalized lower extremity
symptoms and signs, such as heaviness and
swelling, are classified with CEAP not SVP.a
c Venous claudication.a
PeVD, Pelvic venous disorder; SVP, symptoms-Varices-Pathophysiology.
aMust include CEAP classification for full characterization of lower
extremity symptoms.
Table III. Varices (“V”)
V0
No abdominal, pelvic, or pelvic origin extrapelvic
varices on clinical or imaging examination
V1 Renal hilar varices
V2 Pelvic varices
V3 Pelvic origin extrapelvic varices.
a Genital varices (vulvar varices and varicocele)
b Pelvic origin lower extremity varicose veins arising
from the pelvic escape points and extending into
the thigh. Includes visible varicosities, typically over
the posteromedial thigh, as well as sciatic varices
and other refluxing veins transitioning the pelvic
floor which are visualized only with ultrasound.a
aMust include CEAP classification for full characterization of lower
extremity varices.
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bleeding, and superficial thrombosis are included in
S3a and S3b, to avoid redundancy and potentially
compromised reproducibility, generalized lower extrem-
ity signs (eg, swelling) and symptoms (eg, HASTI symp-
toms associated with C2S) are not specifically included
in SVP and must be further classified using CEAP. Pa-
tients presenting with more than one clinical symptom
should have all presenting features included as sub-
scripts, separated by commas, following the S
designation.
Varices (V). The venous system of the pelvis can be
considered to consist of 3 reservoirs where varices may
developd(1) the renal hilum, (2) the venous plexuses of
the pelvis, and (3) the pelvic origin extrapelvic veins. The
lower extremity veins comprise a fourth reservoir, which
may communicate with pelvic origin extrapelvic varices.
However, as with symptoms, the lower extremity reser-
voir is optimally defined with CEAP and is not included
in SVP.
Increased venous pressures, arising from proximal
reflux or obstruction, are transmitted to these reservoirs,
where symptoms related to either varices or increased
venous pressure may develop. Most therapeutic interven-
tions are directed toward decreasing venous pressure in
these reservoirs. The variceal reservoirs of the pelvis are
designated V and are again denoted in a descending
fashion by the subscripts 0 to 3 (Fig 1; Table III).
Although some varices (eg, pelvic origin varices of the
vulva or posteromedial thigh) may be apparent on phys-
ical examination, others (renal hilar, pelvic, and some pel-
vic origin extrapelvic varices) are identified only through
imaging studies. The V classification should, therefore,
include the full extent of varices defined by both physical
examination and imaging studies. As with symptoms,
patients presenting with varices in more than one reser-
voir should have all of their presenting features included
as multiple subscripts, separated by commas, to V.
Finally, because the pelvic and lower extremity venous
systems are in continuity, patients with lower extremity
signs and symptoms arising in the pelvis should be
described using both SVP and CEAP as complementary
instruments.
Pathophysiology (P). The pathophysiology domain (P)
is a composite of the anatomic (A), hemodynamic (H),
and etiologic (E) subdomains. Involved anatomic seg-
ments in the abdomen and pelvis are designated by
anatomic abbreviations that include laterality (Table IV).
As in CEAP, the underlying hemodynamic (H)
derangementsdreflux (R), obstruction O), or both (R,O)
dare designated by a subscript to the P category
(Table V). Obstruction, which may be thrombotic or non-
thrombotic in origin, primarily involves the left renal,
common iliac, and external iliac veins. Reflux occursmost commonly in the gonadal veins, internal iliac veins,
and pelvic escape points with their associated pelvic
origin extrapelvic veins. By convention, the hemody-
namic subscript should immediately follow the designa-
tion of each involved anatomic segment. In contrast with
the lower extremities, concurrent reflux and obstruction
in a single pelvic venous segment is unusual but, if pre-
sent, should be designated by both the R and O sub-
scripts. Also, some congenital malformations, may not
be associated with either reflux or obstruction, in which
case the H subscript should be omitted.
The etiology (E) of pelvic venous pathology is defined as
being thrombotic (T), nonthrombotic (NT), or congenital
(C) (Table VI). Venous obstruction can arise from either
a previous episode of deep venous thrombosis
Table IV. Anatomy
Abbreviation Expansions
IVC Inferior vena cava
LRV Left renal vein
GV Gonadal (testicular, ovarian) veins
LGV Left gonadal vein
RGV Right gonadal vein
BGV Bilateral gonadal veins
CIV Common iliac veins
LCIV Left common iliac vein
RCIV Right common iliac vein
BCIV Bilateral common iliac veins
EIV External iliac veins
LEIV Left external iliac vein
REIV Right external iliac vein
BEIV Bilateral external iliac veins
IIV Internal iliac veins
LIIV Left internal iliac vein and tributaries
RIIV Right internal iliac vein and tributaries
BIIV Bilateral internal iliac veins and tributaries
PELV Pelvic escape veins22 (“escape points”); inguinal,




Thrombotic or nonthrombotic (venous
compression) venous obstruction
Reflux (R) Thrombotic or nonthrombotic reflux
Table VI. Etiology (E)
Thrombotic (T)
Venous reflux or obstruction arising
from a previous episode of DVT
Nonthrombotic (NT) Reflux arising from a degenerative
process of the vein wall or proximal
obstruction; Obstruction arising
from extrinsic compression
Congenital (C) Congenital venous or mixed vascular
malformations
DVT, Deep vein thrombosis.
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rial structures or mass lesions (nonthrombotic). Throm-
botic reflux can similarly develop after an episode of
deep venous thrombosis, whereas nonthrombotic reflux
is presumed to represent a degenerative process of the
vein wall leading to venous dilation and valvular incom-
petence. Congenital etiologies include vascular malfor-
mations, either venous or mixed. The designated
etiology (E) should be denoted by a subscript to the P
category, immediately after the designation of the
involved anatomic segments and the hemodynamic
derangements.
Using the SVP classification. For the purposes of docu-
menting reproducibility of the instrument and for
recording data in clinical studies, all five domains and sub-
domains of SVPdS, V, A, H, andEdshould bedocumented
independently. However, such a system is overly compli-
cated for routine clinical use and communication. For
such purposes, the A, H, and E subdomains are collapsed
into a single anatomic-pathophysiological domain P. By
convention, this single term should include the anatomic
segment(s) involved, the underlying hemodynamics, and
the etiology in this order. That is, notation for the P domain
should be P anatomic segment, hemodynamics, etiology. If multiple
anatomic segments are involved, each venous segment
after the P should be specified in this fashion, separating
the full anatomic-pathophysiologic description of each
segment with a semicolon. In such cases, the anatomicsegments and associated pathology should be listed
beginning at the inferior vena cava and proceeding
caudally. For example, nonthrombotic obstruction of the
left common iliac vein associated with internal iliac reflux
should be designated as PLCIV,O,NT; LIIV,R,NT. The historic
syndromes of the abdomen and pelvis would be now be
designated as follows in the SVP classification,
d Pelvic congestion syndrome with chronic pelvic pain
due to bilateral ovarian reflux: S2V2PBGV,R,NT
d Nutcracker syndrome with flank pain and hematuria:
S1V1PLRV,O,NT
d May-Thurner syndrome with left lower extremity
edema: S0V0PLCIV,O,NT; Left C3sEseAdPo(CIV)
Clinical examples of the SVP classification are shown in
Figs 2 to 9. The use of a scoring sheet as shown in
Table VII may aid in early application of the instrument.
Smart phone applications to assist in classification are
available on the AVLS website (https://myavls.org/svp).
All components of the instrument, that is S, V, and PA,H,E
are to be used in designating a patient’s final SVP classi-
fication. This presumes imaging (abdominal/transperi-
neal ultrasound, transvaginal ultrasonography, cross-
sectional imaging, venography/IVUS, laparoscopy) has
been done as part of the classification, recognizing that
some components of the classification may change as
the evaluation progresses from noninvasive to more
definitive imaging such as venography. It is acceptable
to use an interim designation (x) as a subscript for those
domains where evaluation is not yet complete (eg, S0-
3VxPx).
DISCUSSION
Despite technical advances, progress in the diagnosis
and management of PeVDs has been hampered by the
use of historic nomenclaturedthe May-Thurner, pelvic
congestion, and nutcracker syndromesdto describe
Fig 2. Left renal vein compression associated with symptoms of left flank pain and hematuria. A, Computed
tomography (CT) demonstrates compression of the left renal vein (white arrow) over the abdominal aorta. B,
Venography demonstrates contrast attenuation over the abdominal aorta (black arrow), renal hilar varices (white
arrow), and ascending collaterals (dashed white arrow) consistent with renal vein compression. The Symptoms-
Varices-Pathophysiology (SVP) classification is S1V1PLRV,O,NT.
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ical presentations. The use of these terms ignores the
complex and interrelated abdominal and pelvic venous
circulation, as well as the observation that similar clinical
presentations may have different underlying pathophys-
iologies while identical pathology may have different
clinical presentations. Inaccuracy in precisely character-
izing a patient’s clinical presentation has often led to
misdiagnosis and suboptimal treatment outcomes and
has hindered progress in the field. The use of the histor-
ical syndromic terms should be abandoned in favor of a
more precise characterization of the patient’s clinicalFig 3. Chronic pelvic pain due to compression of the left re
Selective renal venography demonstrates compressive ob
(black arrow) associated with renal hilar varices. The left ren
star) and a refluxing left ovarian vein (white star). B, Selec
pelvic varices, myometrial veins (red star) and small
Pathophysiology (SVP) classification is S2V1,2PLRV,O,NT; LGV,R,Npresentation, including symptoms, signs (varices), and
the underlying venous anatomy and pathophysiology.1
Although incomplete, our understanding has progressed
to the point that a discriminative instrument is needed
to characterize patients with PeVD.
Discriminative instruments characterize a patient’s clin-
ical presentation at a particular point in time. From a
pragmatic standpoint, such instruments place patients
into categories with similar clinical features, natural his-
tories, and responses to treatment. By virtue of their
fundamental features (large between subject variability),
these instruments are not designed to quantitativelynal vein with secondary reflux in the left ovarian vein. A,
struction (white arrow) of the central left renal vein
al vein is drained through the renal-azygous trunk (red
tive left ovarian venography demonstrates associated
arcuate veins (red arrow). The Symptoms-Varices-
T.
Fig 4. Left flank pain associated with chronic microscopic hematuria and pelvic pain. Selective renal venography
(1) demonstrates a left inferior pole renal venous malformation (black arrow) drained by a left ovarian vein with no
visible connection to the renal vein. Pelvic venography (2) shows associated pelvic varicosities (white star). The
Symptoms-Varices-Pathophysiology (SVP) classification is S1,2V1,2PLRV,C; LGV,R,NT.
578 Meissner et al Journal of Vascular Surgery: Venous and Lymphatic Disorders
May 2021measure either severity or change over time or in
response to treatment, which is the role evaluative instru-
ments. Although both types of instrument depend on a
high ratio of signal to noise (low measurement error),
for discriminative instruments the signal is differences
between subjects, whereas for evaluative instruments it
is longitudinal changes within subjects.7 Responsiveness
to change is not a primary concern for discriminative in-
struments. This dichotomy is well-illustrated for lower ex-
tremity venous disorders. CEAP2-4 was designed as a
purely discriminative instrument, whereas the Venous
Clinical Severity Score55,56 is its evaluative complement.
The development of disease-specific evaluative instru-
ments for PeVD is in its infancy but depends on defining
homogenous patient populations with instruments such
as the SVP classification. For example, patient-reported
outcomes for symptomatic left common iliac venous
obstruction associated with lower extremity symptoms
would be very different than if associated with chronic
pelvic pain.
Because the pelvic venous system is in continuity with
that of the lower extremities and can be the origin of
lower extremity signs, compatibility with the CEAP classi-
fication was considered to be important. This factor was
thoroughly considered by the panel, which ultimately
concluded that, although the basic clinical, etiologic,
anatomic, and pathophysiologic domains of CEAP are
equally relevant to PeVD, many unique considerations
prevent a precise alignment between discriminative in-
struments for PeVD and chronic lower extremity venous
disease. Most importantly, whereas the CEAP clinical
classification (C) focuses on the signs of venous disease,patient-important features of pelvic venous disease
necessarily include both symptoms and signs (varices).
Furthermore, although lower extremity varices largely
develop in the distribution of the saphenous trunks and
their tributaries, symptomatic varices in the abdomen
and pelvis may occur in multiple beds or reservoirs,
including the renal hilum, the pelvic venous plexus, the
transition (escape) points between the pelvis and lower
extremities, and the lower extremities.
The situation is further complicated by the observation
that symptoms of pelvic reflux or obstruction may be
related to the development of increased venous pressure
in the immediately upstream (considering normally
directed venous flow from peripheral to central) venous
reservoir or, if decompressed from one reservoir to
another via refluxing collaterals, to more caudal venous
reservoirs. Although occurring between all variceal reser-
voirs,57 this phenomenon has been most thoroughly
described for symptomatic compression of the left renal
vein, which may be associated with either an elevated
(noncompensated) or normal to borderline abnormal
(compensated) transrenal pressure gradient in the pres-
ence of collaterals.30,31 Left renal vein obstruction may
accordingly be associated with symptoms of flank pain
and hematuria (noncompensated obstruction) or with
chronic pelvic pain (compensated obstruction) if decom-
pressed by left ovarian vein collaterals. In a similar
fashion, increased venous pressure owing to reflux or
obstruction in any of the three anatomic zones included
in the SVP instrument, may be transmitted to a more
caudal zone by collateral reflux flow (compensated reflux
or obstruction).57 The clinical implication is that similar
Fig 5. Chronic pelvic pain due to bilateral primary ovarian
vein reflux. A dilated, refluxing left ovarian vein (black ar-
row) is associated with multiple pelvic varicosities (white
arrow). Right ovarian vein reflux is also present, but not
demonstrated in this image. No obstruction of the left
renal or common iliac veins or internal iliac reflux is pre-
sent by ultrasound examination. The Symptoms-Varices-
Pathophysiology (SVP) classification is S2V2PBGV,R,NT.
Fig 6. Chronic pelvic pain due to left common iliac
compression. The patient has no lower extremity symp-
toms. Transabdominal ultrasound examination (not
shown) demonstrates >50% compression of the left
common iliac vein, retrograde flow in the left internal iliac
vein, and periuterine varices. Intravascular ultrasound
(IVUS) (not shown) demonstrates 70% cross-sectional area
reduction of the left common iliac vein at the crossing of
the right common iliac artery. Antegrade venography
demonstrates flattening of the left common iliac vein with
contrast attenuation at the arterial crossing (black arrow)
and left internal iliac reflux (white arrow). Associated pelvic
varices are better seen on delayed imaging (not shown).
The Symptoms-Varices-Pathophysiology (SVP) classifica-
tion is S2V2PLCIV,O,NT; LIIV,R,NT.
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may arise from diverse anatomic-pathophysiologic pat-
terns, whereas, depending on the degree of collateraliza-
tion, similar anatomic-pathophysiologic lesions may be
associated with variable symptoms.
Despite these differences, the manifestations of pelvic
and lower extremity venous disease are a continuum
that frequently coexist and there is a clear need to use
CEAP as a complement to any proposed pelvic venous
classification. The SVP classification has the granularity
needed to account for the complex and interrelated na-
ture of pelvic symptoms and pathophysiology, whereas
CEAP accurately characterizes the signs of lower extrem-
ity venous disease, even if the pathophysiologic derange-
ments arise in the pelvis. Reasonable attempts have
been made to make the instruments congruent byincorporating the anatomic and physiologic conventions
that are familiar to users of CEAP. The overlap between
the two instruments are (a) refluxing veins traversing
the pelvic escape points and (b) the transmission of
increased venous pressure from iliocaval venous obstruc-
tion to the lower extremities. These veins, as well as their
pathophysiologic origins are precisely described in SVP
(eg, V3bPPELV,R,NT) and more generally in the recent revi-
sion of CEAP (eg, P(r)Pelv).
4 In contrast, CEAP more pre-
cisely defines the subsequent communications and
clinical manifestations of these veins in the legs. The in-
struments are, therefore, to be used together in limbs
with pelvic origin lower extremity symptoms (S3b and
S3c) and signs (V3b).
Fig 7. Symptomatic vulvar varicosities with associated
pelvic pain due to bilateral ovarian and internal iliac
venous reflux. There are no associated lower extremity
varices. Transabdominal ultrasound (not shown) shows
periuterine varices with bilateral ovarian and internal iliac
reflux and no evidence of left renal or common iliac
venous obstruction. Balloon occlusion venography per-
formed from a left internal iliac injection demonstrating
vulvar varicosities associated with the internal (black ar-
row) and external (white arrow) pudendal veins. Similar
reflux through the pudendal veins is present on the right.
Ovarian and right internal iliac vein injections not shown.
The Symptoms-Varices-Pathophysiology (SVP) classifica-
tion is S2,3aV2,3aPBGV,R,NT; BIIV,R,NT; BPELV,R,NT.
Fig 8. Post-thrombotic venous claudication and left lower
extremity swelling without visible lower extremity varices.
Ultrasound (not shown) demonstrates post-thrombotic
reflux with partial obstruction in the left common
femoral, femoral, and popliteal veins, and no superficial
venous reflux. The figure shows post-thrombotic changes
in the left common and external iliac veins (black arrows)
with large obturator collaterals (dashed white arrow)
draining into the left internal iliac vein (solid white arrow).
Collateral veins with antegrade flow bypassing an
obstruction are not considered varices by the Symptoms-
Varices-Pathophysiology (SVP) instrument. Because the
presentation involves lower extremity symptoms and
signs, the SVP classification should be used in conjunction
with the CEAP classification. The SVP classification is
S3cV0PLCIV,O,T; LEIV,O,T; Left C3sEsiAdP(o)CIV, EIV; (r,o)CFV,FV,POPV.
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ing features in terms of signs, symptoms, and the under-
lying pathophysiology. However, there are some caveats
to be considered in using the instrument. The instrument
is a purely discriminative instrument and carries no
implication of disease severity. As with CEAP, the re-
sponses within each domain are categorical variables
that should be described by absolute numbers and per-
centages rather than by a mean score. Furthermore, the
SVP presumes an underlying venous etiology to the pa-
tient’s clinical presentation and does not include similar
Fig 9. Locally painful, recurrent, left medial thigh varicos-
ities in 56-year-old G3P3 female 21 years after great
saphenous stripping. She has no pelvic symptoms. Ultra-
sound examination (not shown) demonstrates reflux in
the bilateral ovarian and left internal iliac veins associated
with pelvic varices communicating with the extrapelvic
varices over the left medial thigh. No right internal iliac or
superficial or deep lower extremity reflux is seen on ul-
trasound. Venography demonstrates pelvic origin varices
over the medial thigh communicating with pudendal
(black arrow) and inguinal (red arrow) tributaries of the left
internal iliac vein. The Symptoms-Varices-Pathophysiology
(SVP) classification is S3bV2,3bPBGV,R,NT; LIIV,R,NT; LPELV,R,NT ;
Left C2s,rEpAs,dP(r) IIV,Pelvic,NSV.
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Finally, although interim designations are allowed, com-
plete classification will usually only be possible once
initial diagnostic studies are completed. Abbreviated
forms of SVP were considered, similar to basic CEAP,3
but truncating the full anatomic-pathophysiologic
description of a patient’s presentation resulted in poten-
tially misleading overlaps in classification. For example, if
the classification was abbreviated to SVPH, chronic pelvic
pain due to either left renal vein or iliac vein compression
would be identically classified as S2V2PR,O.The SVP instrument attempts to comprehensively
describe a patient’s clinical presentation. The inclusion
of additional descriptive subdivisions beneath the ele-
ments of some domains was considered, but ultimately
deferred due to concerns of making the instrument
overly complicated and limiting initial adoption. Addi-
tional subdivisions that were considered included the
following.
a) Subcategorization of S1 (venous origin renal symp-
toms) to include separate designations for flank pain
and hematuria.
b) Subcategorization of S2 (chronic pelvic pain) to
include sexual, menstrual, urinary, and defacatory
symptoms.
c) Subcategorization of S3 to include hemorrhoids.
Some investigators have reported a relationship be-
tween PeVDs and hemorrhoids. For example, hemor-
rhoids on transvaginal ultrasound have been noted
in 36.3% of women presenting with pelvic origin lower
extremity reflux.58 Although the internal rectal (hem-
orrhoidal) plexus drains primarily through the inferior
mesenteric vein via the superior rectal vein, there is
some contribution from the middle rectal tributary
of the internal iliac vein. The external rectal plexus
drains through the middle and inferior rectal tribu-
taries of the internal iliac vein. However, there are
communications between all three rectal veins, allow-
ing drainage into both the portal and systemic circu-
lation.22,59 There are also anecdotal reports of
improvement in hemorrhoidal symptoms after pelvic
venous embolization,60 although the effectiveness of
phlebotonic agents, such as micronized purified flavo-
noid fraction, has been inconsistent.61,62 Despite these
observations, the pathophysiology of hemorrhoids is
more complex than simple venous dilation59,61,63 and
their relationship to other PeVDs is not clear. Although
at present there is insufficient evidence to support a
strong relationship between hemorrhoids and PeVDs,
this area warrants further investigation.
d) More precisely characterizing lower extremity venous
symptoms and signs, beyond those of pelvic origin
extrapelvic varices (S3b, V3b), by adding additional sub-
divisions of each. That is, more precisely defining signs
and symptoms arising from each of the pelvic escape
points.
The strengths of the SVP instrument include its collab-
orative multidisciplinary development, ensuring that the
spectrum of clinical presentations encountered by multi-
ple specialties is well-represented. In addition to accu-
rately describing and classifying the spectrum of
clinical presentations, the other goals of instrument
development were to ensure that it included patient
important domains and that it had high reproducibility.
The instrument’s domains and responses are, therefore,
precisely defined with minimal overlap between groups
Table VII. Symptoms-Varices-Pathophysiology (SVP) classification scoring sheet
Symptoms (S) Varices (V)
Anatomy/pathophysiology (P)
A H E
No pelvic symptoms 0 No pelvic varices 0 IVC O T
Renal 1 Renal 1 NT
Pelvic 2 Pelvic 2 C
Extrapelvic 3 Extrapelvic 3 L RV O T
Genital 3a Genital 3a NT
Leg symptoms 3b Leg varices 3b C
Venous claudication 3c R GV O T
L R NT
B C
R CIV O T
L R NT
B C
R IIV O T
L R NT
B C
R EIV O T
L R NT
B C
R PELV O T
L R NT
B C
S V Psegment1,H,E;segment 2,H,E
A, Anatomic; H, hemodynamic; C, congenital; CIV, common iliac veins; E, etiologic; EIV, external iliac veins; GV, gonadal (testicular, ovarian) veins; IIV,
internal iliac veins; IVC, inferior vena cava; L, left; NT, nonthrombotic; O, obstruction; PELV, pelvic escape veins22 (“escape points”); inguinal, obturator,
pudendal, and/or gluteal; R, reflux; RV, renal vein; S, symptoms; T, thrombotic; V, varices.
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made to ensure the definitions were evidence based
and as precise as possible, recognizing that there are de-
ficiencies in the current literature. The underlying patho-
physiology and involved anatomic segments are similarly
precisely described.
The SVP instrument does have some limitations.
Although members of the multidisciplinary panel were
all experts in their respective fields, patient representa-
tives were not included and may have identified other
factors of importance to patients. Additionally, the
knowledge base with respect to PeVD is rapidly
advancing and it is fully recognized that future revisions
with be required. For example, there are no consistent
and widely accepted diagnostic criteria for most
PeVD.46 Because many definitions are based on noninva-
sive imaging studies with variable diagnostic criteria, def-
initions were occasionally problematic and it is
anticipated that these will be refined as the field ad-
vances. Although every effort was made to ensure that
definitions were precise and that reproducibility was
acceptable in simulated classification exercises, the in-
strument awaits clinical validation.It is also anticipated that there will be resistance to
abandoning the historic nomenclature for PeVD and
that the SVP classification will be criticized as being
overly complex for clinical use. Despite bringing
much-needed clarity to lower extremity venous disor-
ders, the CEAP classification has been similarly criti-
cized. However, with increasing familiarity, CEAP has
been successfully adopted by most clinicians and inves-
tigators and has become the international standard for
the classification of lower extremity venous disorders.
Despite efforts to make the classification of PeVDs as
simple as possible, it must be appreciated that PeVD
are quite complex with variable, but interrelated hemo-
dynamic and clinical features that cannot be
adequately described by the current nomenclature. As
with CEAP, the nuances of the SVP classification cannot
be appreciated from simply reading this manuscript.
Comfort and familiarity with the classification, as well
as identification of additional limitations, can only
come with routine use. It is hopeful that use of
Table VII, as well as an electronic version that is avail-
able through https://myavls.org/svp, will aid in initial
adoption of the SVP classification.
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greater scientific rigor to PeVDs. It is presumed that,
much like lower extremity CEAP, the instrument will be
carefully studied and any deficiencies addressed in
future revisions. However, it is only through the precise
definition of homogenous patient populations that clin-
ical care can be optimized, appropriate outcome instru-
ments developed, and rigorous clinical trials conducted.REFERENCES
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